The growth inhibition of colorectal adenoma cells by sulindac and its mechanisms

Journal of West China University of Medical Sciences

Volumn 33, Issue 1, 2002, Pages 101-103

  Huang, Libin ^a   Ouyang, Qin ^a   Wei, Dapeng ^a   Liu, Xiaofang ^a   Hu, Renwei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Colorectal adenoma cells; Growth inhibition; Sulindac

Indexed keywords

SULINDAC; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE;

ADENOMA; ADENOMATOUS POLYP; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CANCER; COLORIMETRY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; CELL CULTURE; CELL DIVISION; COLON TUMOR; DRUG EFFECT; FEMALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADENOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CELL DIVISION; COLONIC NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULINDAC; TUMOR CELLS, CULTURED;

EID: 1842834285     PISSN: 02577712     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne colorectal cancer study. Cancer Res, 1988; 48(15):4399
2. Kauppi M, Pukkala E, Isomaki H. Low incidence of colorectal cancer in patients with rheumatoid arthritis. Clin Exp Rheumatol, 1996; 14(5):551
3. Giardello FM, Hamicton SR, Krash AJ, et al. Treatment of colonic rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med, 1993; 328(18):1313
4. Matsuhashi N, Nakajima A, Fukushima Y, et al. Effects of sulindac on sporadic colorectal adenomatous polyps [See comments]. Gut, 1997; 40(3):344
5. Winawer SJ, Zauber AG, Nah HM, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med, 1993; 329(27):1977
6. Stolk RUV, Beck GJ, Baron JA, et al. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. Gastroenterology, 1998; 115(1):13
7. Elder DJE, Hague A, Hicks DJ, et al. Differential growth inhibition by aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res, 1996; 56(10):2273
8. Sheng H, Shao J, Morrow JD, et al. Modulation of apoptosis and bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res, 1998; 58(2):362
9. Maekawa M, Sugano K, Sano H, et al. Increased expression of cyclooxygenase-2 to -1 in human colorectal cancer and adenomas, but not in hyperplastic polyps. Jpn J Clin Oncol, 1998; 28(7):421